197 related articles for article (PubMed ID: 34344926)
1. Comprehensive analysis of the expression and prognosis for TNFAIPs in head and neck cancer.
Lan G; Yu X; Sun X; Li W; Zhao Y; Lan J; Wu X; Gao R
Sci Rep; 2021 Aug; 11(1):15696. PubMed ID: 34344926
[TBL] [Abstract][Full Text] [Related]
2. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
[TBL] [Abstract][Full Text] [Related]
3. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
4. Tumor Necrosis Factor Alpha-Induced Proteins in Malignant Tumors: Progress and Prospects.
Guo F; Yuan Y
Onco Targets Ther; 2020; 13():3303-3318. PubMed ID: 32368089
[TBL] [Abstract][Full Text] [Related]
5. Pseudogene Transcripts in Head and Neck Cancer: Literature Review and
Carron J; Della Coletta R; Lourenço GJ
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440428
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
7. Expression of chemokine CXCL8/9/10/11/13 and its prognostic significance in head and neck cancer.
Zhao Z; Ma Y; Lv J; Maimaiti N; Zhang J; Aibibula M; Gong Z; Ling B
Medicine (Baltimore); 2022 Jul; 101(30):e29378. PubMed ID: 35905218
[TBL] [Abstract][Full Text] [Related]
8. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
9. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.
Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W
Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor.
Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y
Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer.
He Z; Yue C; Chen X; Li X; Zhang L; Tan S; Yi X; Luo G; Zhou Y
J Cancer; 2023; 14(1):72-87. PubMed ID: 36605482
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
[TBL] [Abstract][Full Text] [Related]
15. Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.
Sarkar S; Alam N; Mandal SS; Chatterjee K; Ghosh S; Roychoudhury S; Panda CK
PLoS One; 2018; 13(4):e0195937. PubMed ID: 29672635
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.
Kumarasamy C; Madhav MR; Sabarimurugan S; Krishnan S; Baxi S; Gupta A; Gothandam KM; Jayaraj R
Cells; 2019 Jul; 8(8):. PubMed ID: 31349668
[TBL] [Abstract][Full Text] [Related]
17. Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours.
Cossu AM; Mosca L; Zappavigna S; Misso G; Bocchetti M; De Micco F; Quagliuolo L; Porcelli M; Caraglia M; Boccellino M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336999
[TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
19. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
20. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]